moxalactam has been researched along with beta-lactams in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (76.19) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Hashizume, T; Sawai, T; Yamaguchi, A | 1 |
| Cynamon, MH; Granato, PA | 1 |
| McNamara, BT; Meyer, RD; Pasiecznik, KA | 1 |
| Hofstra, H; van der Waaij, D; Wiegersma, N | 1 |
| Brown, JE; Collins, CD; Del Bene, VE | 1 |
| Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C | 2 |
| Verbist, L | 1 |
| Slack, MP | 1 |
| Neu, HC | 1 |
| Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
| Motokawa, K; Murakami, K; Takasuka, M; Yoshida, T | 1 |
| Crokaert, F; Labbé, M; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
| Adamsson, L; Dornbusch, K; Gezelius, L; Hallander, H | 1 |
| Beadle, BM; Nicholas, RA; Shoichet, BK | 1 |
| Minasov, G; Shoichet, BK; Wang, X | 1 |
| Arlet, G; Bingen, E; Drieux, L; Mammeri, H; Pluquet, E | 1 |
| He, L; Ke, H; Yuan, Q | 1 |
| Babnigg, G; Burdette, SC; Endres, M; Henning, RW; Joachimiak, A; Kim, Y; Lavens, A; Lazarski, K; Maltseva, N; Sherrell, DA; Shigemoto, A; Srajer, V; Wilamowski, M | 1 |
2 review(s) available for moxalactam and beta-lactams
| Article | Year |
|---|---|
Antipseudomonal beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1981 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
19 other study(ies) available for moxalactam and beta-lactams
| Article | Year |
|---|---|
Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cell Membrane Permeability; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins | 1986 |
In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Tobramycin | 1982 |
In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalothin; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1982 |
Effect of beta-lactam antibiotics of the resistance of the digestive tract of mice to colonization.
Topics: Animals; Anti-Bacterial Agents; Azlocillin; beta-Lactams; Cefuroxime; Cephamycins; Dose-Response Relationship, Drug; Enterobacter; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Feces; Female; Intestines; Mezlocillin; Mice; Moxalactam; Penicillins | 1982 |
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins | 1981 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1980 |
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Moxalactam | 1981 |
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Enterobacteriaceae Infections; Fermentation; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
1-Oxacephalosporins: enhancement of beta-lactam reactivity and antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporinase; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Microbial Sensitivity Tests; Moxalactam | 1981 |
The effect of beta-lactam antibiotics on the growth curves of Bacteroides fragilis, obtained with the MS-2 system.
Topics: Anaerobiosis; Bacteroides fragilis; beta-Lactams; Carbenicillin; Cefoxitin; Cell Division; Cephamycins; Dose-Response Relationship, Drug; Kinetics; Microbial Sensitivity Tests; Moxalactam; Penicillin G | 1981 |
In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Culture Media; Drug Stability; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |
Interaction energies between beta-lactam antibiotics and E. coli penicillin-binding protein 5 by reversible thermal denaturation.
Topics: Acylation; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carrier Proteins; Cefoxitin; Circular Dichroism; Cloxacillin; Escherichia coli; Hexosyltransferases; Imipenem; Models, Chemical; Moxalactam; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Protein Denaturation; Spectrometry, Fluorescence; Temperature; Thermodynamics | 2001 |
Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Energy Metabolism; Enzyme Inhibitors; Enzyme Stability; Imipenem; Macromolecular Substances; Models, Chemical; Models, Molecular; Moxalactam; Protein Conformation; Protein Denaturation; Temperature | 2002 |
Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Drug Resistance, Bacterial; Gram-Negative Aerobic Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxalactam; Staphylococcus | 1981 |
Sensitive and specific phenotypic assay for metallo-beta-lactamase detection in Enterobacteria by use of a moxalactam disk supplemented with EDTA.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Culture Media; Edetic Acid; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam | 2011 |
A potential substrate binding conformation of β-lactams and insight into the broad spectrum of NDM-1 activity.
Topics: beta-Lactamases; beta-Lactams; Catalytic Domain; Clavulanic Acid; Klebsiella pneumoniae; Moxalactam; Protein Binding; Protein Conformation | 2012 |
Time-resolved β-lactam cleavage by L1 metallo-β-lactamase.
Topics: beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Moxalactam | 2022 |